A study on cancer patients receiving chemotherapy to identify the occurrence of depression in those cancer patients using questionnaire tools.
- Conditions
- Health Condition 1: null- cancer patients undergoing chemotherapy treatment
- Registration Number
- CTRI/2014/09/005064
- Lead Sponsor
- JAMIA HAMDARD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 20
•Patients must have histologically or cytologically confirmed cancer
•Patients receiving chemotherapy for the treatment of cancer
•Both male and female patients
•Patients capable of giving informed consent
•Patients willing to participate in the study
•History of major depression
•Meet the DSM-IV criteria for a major depressive episode.
•Meet criteria for treatment resistant depression defined by failure to, respond to, or intolerance of, at least 2 treatments of antidepressants
•Active suicidal ideation
•History of any major operation in past 6 months excluding surgeries related to cancer treatment
•History of any significant cognitive impairment in past
•On any psychotropic medications
•Presence of any other concurrent illness(Parkinson disorder; Vascular disorders like Hypertension, Stroke; Endocrine disorders like Type II Diabetes Mellitus, Hypothyroidism; AIDS/HIV and rheumatoid arthritis)
•Using any concurrent medication like clonidine, methyldopa, isotretinoin, phenobarbital, levetiracetam, phenytoin, triptans and hormonal agents (corticosteroids, oral contraceptives, GnRH agonists and tamoxifen) or whose side effect is depression
•Suffered anxiety episodes in past
•History of Schizophrenia
•Alcoholics
•Habit of any substance of abuse
•History of significant dementia or intellectual disability
•Incompetent for interview
•Psychological, familial, sociological, or geographical conditions that do not permit treatment or medical follow-up and / or prohibit compliance with the study protocol
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method prevalence of depression among cancer patientsTimepoint: patients will be assessed initially at the baseline and the consecutively up to two cycles of chemotherapy
- Secondary Outcome Measures
Name Time Method to evaluate the incidence of depression according to age,gender, education, stage of cancer,type of cancer, types of chemotherapeutic regiments and cycles of chemotherapyTimepoint: baseline and then up to three cycles of chemotherapy